R Squared’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
R Squared's TVTX Position: Q3 2026 in Review
R Squared opened a new position in Travere Therapeutics (TVTX) in Q3 2026: 4,129 shares worth $243K. The stake represents 0.13% of the portfolio and ranks #283 among its holdings. This is a return to the name: R Squared previously reported a position in TVTX as recently as Q4 2024.
R Squared first reported a position in TVTX in Q4 2024 and has held it in 2 quarters since. 345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.
- R Squared held 4,129 shares of Travere Therapeutics worth $243K as of Q3 2026.
- Travere Therapeutics was a new R Squared position in Q3 2026.
- Travere Therapeutics made up 0.13% of R Squared's portfolio in Q3 2026, its #283 holding.
- R Squared first reported a position in Travere Therapeutics in Q4 2024 and has held it in 2 quarters since.
- 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.
Based on R Squared's 13F filing for Q3 2026, filed 6 Nov 2026.